Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Import Bill Endorsed By Kessler; Beats “Uncontrolled Risk”

Executive Summary

Legislation to create a regulated system for importing drugs would be safer than the current system of unregulated personal importation, former FDA Commissioner David Kessler told a Senate Health Committee hearing April 19

You may also be interested in...



Drug Importation Is “Diminishing,” NACDS CEO Fuller Says

Anecdotal evidence suggests that drug importation from Canada is declining, National Association of Chain Drug Stores CEO Craig Fuller said May 2

Drug Importation Is “Diminishing,” NACDS CEO Fuller Says

Anecdotal evidence suggests that drug importation from Canada is declining, National Association of Chain Drug Stores CEO Craig Fuller said May 2

Reimportation Bill From Dorgan/Snowe Includes User Fees To Fund Oversight

A reimportation bill reintroduced by Sens. Byron Dorgan (D-N.D.) and Olympia Snowe (R-Maine) includes user fees for importers and foreign exporters to fund FDA's safety oversight

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel